Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-10

FDA Approved: ONGENTYS — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for ONGENTYS (opicapone) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONGENTYS (opicapone)

Snippet

SUPPL AP for ONGENTYS (OPICAPONE)